Cite
MLA Citation
WW Busse et al.. “S31 Dupilumab reduces severe exacerbations across baseline disease characteristics in patients with elevated baseline type 2 biomarkers: the LIBERTY ASTHMA QUEST study.” Thorax, vol. 74, n.d., pp. A21–A22. http://access.bl.uk/ark:/81055/vdc_100135173763.0x000025